Victor Peperzak obtained his PhD at the Netherlands Cancer Institute (NKI) in Amsterdam examining the underlying mechanisms of T cell co-stimulation.
He next moved to the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, as a postdoctoral fellow to study the role of pro-survival protein MCL-1 in healthy germinal center B cells and plasma cells. This research line was continued at the AMC in Amsterdam, further studying the regulation of MCL-1 in malignant B cells.
He is currently a Principal Investigator at the Center for Translation Immunology of the UMCU in Utrecht focusing on the biology underlying development of B cell lymphoma and multiple myeloma, and subsequent aims to improve treatment of these cancers.
Short introduction at the workshop Gaming for Lymphoma